RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Curie.Bio
C

Curie.Bio portfolio

Curie.Bio has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Website: curie.bio.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $77.5M.
Latest deal: R1 Therapeutics · Mar 17, 2026.
About this page

It is a venture capital firm based in Cambridge, US, founded in 2022. Its most recent investment on record is R1 Therapeutics's $77.5M Series A round in March 2026, alongside DaVita Venture Group, U.S. Renal Care, Abingworth and 2 others. That company is in Health and bio.

About Curie.Bio

Firm type: Venture capital.
Headquarters: Cambridge, US.
Founded: 2022.
Stages: Seed, Series A.
Sectors: Biotech, Healthtech.
Check size: $5M to $15M.

What Curie.Bio invests in

How Curie.Bio invests

StageDealsCapital in rounds
Series A 1 100%$77.5M

Curie.Bio portfolio companies

CompanyRound with Curie.BioTotal raisedLatest raise
RR1 Therapeutics
Health and bio
Series A · $77.5M$158MSep 30, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Curie.Bio. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Curie.Bio, which is a subset of its real portfolio. API: /api/v1/investors/curie-bio (get a free API key). More: the most active VC firms and new venture capital funds.